FDA Adverse Event Injury Summary report: N

ORA SYSTEM WITH VERIFEYE MESSAGING

MDR report key: 20469182 · Received October 17, 2024

Report

Report Number
2028159-2024-01575
Event Type
Injury
Date Received
October 17, 2024
Date of Event
July 2, 2024
Report Date
December 27, 2024
Manufacturer
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
Product Code
NCF
PMA / PMN Number
EXEMPT
Removal / Correction Number
NA
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION PROVIDED IN H.3., H.6., AND H.11. ALL DEVICE HISTORY RECORDS ARE REVIEWED PRIOR TO PRODUCT RELEASE TO ENSURE THE PRODUCT WAS MANUFACTURED IN COMPLIANCE WITH THE DEVICE MASTER RECORD AND MEETS RELEASE CRITERIA. BASED ON THE INFORMATION OBTAINED, THE ROOT CAUSE OF THE REPORTED EVENT IS INCONCLUSIVE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4). H.10 REFLECTS ALL RELATED REPORT NUMBERS ASSOCIATED WITH THIS PRODUCT EVENT THAT HAVE BEEN SUBMITTED AT THIS TIME.

Additional Manufacturer Narrative · 0

H.3., H.6.: INVESTIGATION, INCLUDING ROOT CAUSE ANALYSIS, IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4). H.10 REFLECTS ALL RELATED REPORT NUMBERS ASSOCIATED WITH THIS PRODUCT EVENT THAT HAVE BEEN SUBMITTED AT THIS TIME.

Description of Event or Problem · 0

A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS IMPLANT, THE PATIENT WAS UNABLE TO TOLERATE THE MULTIFOCAL LENS. THE PATIENT EXPERIENCED SIGNIFICANT GLARE IN THE LEFT EYE, ALONG WITH DISCREPANCIES IN THE INTRAOCULAR LENS CALCULATIONS IN THE SYSTEM, WHICH RESULTED IN AN UNEXPECTED HYPEROPIC OUTCOME AFTER CATARACT SURGERY. ADDITIONALLY, THE PATIENT REPORTED ISSUES WITH GLARE, HEADACHES, AND NAUSEA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1368092 ORA SYSTEM WITH VERIFEYE MESSAGING ABERROMETER, OPHTHALMIC NCF ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 61 YR Male Other| R CLAREON MONARCH IV IOL DELIVERY SYSTEM, INJECTOR.| CLAREON PANOPTIX TORIC TRIFOCAL HYDROPHOBIC IOL.| CLAREON TORIC IOL.| MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D.